Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288145 · ClinicalTrials.gov registry record · Phase 2
Statewide (Rhode Island and Neighboring States) Partnerships for Worksite Weight Management
A Phase 2 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 2
- Development phase
- 1,700
- Enrollment target
NCT00288145: Completed Phase 2 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00288145 is a Phase 2 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 1,700 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1178% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00288145, a Phase 2 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,700 participants
- Enrollment target
Study Summary
The project is designed to test the effectiveness of a multilevel worksite wellness program, based in Rhode Island and nearby neighboring states to impact employee weight, dietary intake and physical activity, compared to an attention placebo condition.
Interventions
- BEHAVIORAL WOW, Working On Wellness weight management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
What the finished NCT00288145 record still lists
NCT00288145 is an interventional study that assigns participants to a tested intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1178% higher).
The record links to 0 conditions, and to 1 intervention - of which WOW, Working On Wellness weight management is the first listed.
NCT00288145 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00288145 about?
NCT00288145 is a clinical study titled "Statewide (Rhode Island and Neighboring States) Partnerships for Worksite Weight Management". The project is designed to test the effectiveness of a multilevel worksite wellness program, based in Rhode Island and nearby neighboring states to impact employee weight, dietary intake and physical activity, compared to an attention placebo condition.
What is the current status of trial NCT00288145?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,700 participants. The study started on 2006-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00288145?
The interventions under investigation include: WOW, Working On Wellness weight management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00288145?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00288145's enrollment target sits among peer trials
1,700 11th of 2000 higher than 1,990 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia